4.7 Article

Curcumin analog L3 alleviates diabetic atherosclerosis by multiple effects

Journal

EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 775, Issue -, Pages 22-34

Publisher

ELSEVIER
DOI: 10.1016/j.ejphar.2016.02.016

Keywords

L3; Analog of curcumin; Diabetic atherosclerosis; Dyslipidemia; Hyperglycemia

Funding

  1. National Natural Science Foundation of China [81173096]
  2. National Science and Technology Foundation of China for Key Projects of Major New Drugs Innovation and Development [2012ZX09103101-028]

Ask authors/readers for more resources

L3, an analog of curcumin, is a compound isolated from a traditional Chinese medicine Turmeric. In this paper, we aims to explore the efficacy of L3 on diabetic atherosclerosis and the related mechanism. The effect of L3 was studied on glucose and lipid metabolism, antioxidant status, atherosclerosis-related indexes and pathological changes of main organs in the mice model of diabetes induced by streptozotocin and high-fat diet. The results showed that L3 treatment could meliorate dyslipidemia and hyperglycemia, reduce oxidative stress, enhance the activity of antioxidases, increase the nitric oxide level in plasma and aortic arch, decrease the production of reactive oxygen species in pancreas and lectin-like oxidized low-density lipoprotein receptor-1 expression in aortic arch, and meliorate the fatty and atherosclerotic degeneration in aortic arch, thereby preventing the development of diabetes and its complications. These results suggested that L3 can alleviate the diabetic atherosclerosis by multiple effects. This study provided scientific basis for the further research and clinical application of L3. (C) 2016 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available